Acute Myocardial Infarction after Switching from Warfarin to Dabigatran

Dabigatran etexilate is a recently approved direct thrombin inhibitor (DTI), which is superior to warfarin in the prevention of stroke and systemic embolism in patients with atrial fibrillation (AF). However, dabigatran use is associated with an increased risk of myocardial infarction (MI) compared...

Full description

Bibliographic Details
Main Authors: Wael Abuzeid, Hatim Al-Lawati, Neil Fam
Format: Article
Language:English
Published: Oman Medical Specialty Board 2015-01-01
Series:Oman Medical Journal
Subjects:
Online Access:http://www.omjournal.org/fultext_PDF.aspx?DetailsID=600&type=fultext